Esperion Therapeutics, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 3.18 USD (At close: Jul 10, 2026) · Market cap 819.46M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company’s marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who require additional lowering of LDL-C. Its product...